ChemicalBook > CAS DataBase List > DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR)

DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR)

DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) Structure
DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR)
  • CAS No.5965-13-9
  • Chemical Name:DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR)
  • CBNumber:CB0501648
  • Molecular Formula:C22H29NO9
  • Formula Weight:451.46696
  • MOL File:5965-13-9.mol
DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) Property
  • Melting point 192 °C (decomp)
  • solubility Freely soluble in water, sparingly soluble in alcohol, practically insoluble in cyclohexane.
  • CAS DataBase Reference 5965-13-9
  • FDA UNII 8LXS95BSA9
Safety
  • HS Code  :2939110000
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal wordWarning
  • Hazard statements H302
  • Precautionary statements P264-P270-P301+P312-P330-P501

DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) Chemical Properties,Usage,Production

  • Chemical Properties White or almost white, crystalline powder.
  • Originator Bicodein,Uquifa
  • Uses Opioid receptor agonist; analgesic
  • Manufacturing Process The codein was reduced by hydrogen in the presence catalyst Pt (or Pd, or Ni) and 7,8-dihydrocodein was obtained.
    To the 7,8-dihydrocodein tartaric acid was added and mixed, in the result 7,8- dihydrocodein bitartrate was obtained.
  • Therapeutic Function Antitussive, Narcotic analgesic
DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) Preparation Products And Raw materials
Raw materials
Preparation Products
DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) Suppliers
Global(0)Suppliers
DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR) Spectrum
5965-13-9, DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR)Related Search:
  • 二氢可待因酒石酸氢盐
  • 酒石酸氢二氢可待因
  • 5965-13-9
  • Hydrocodone Hydrogen Tartrate 2.5-Hydrate EP Impurity B as Hydrogen Tartrate
  • 3β-[(2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12β,14-dihydroxy-5β-card-20(22)-enolide(digoxigenintetrakisdigitoxoside),
  • (4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol (2R,3R)-2,3-dihydroxysuccinate
  • Dihydrocodeine hydrogen tartrate
  • ZGSZBVAEVPSPFM-FFHNEAJVSA-N
  • Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.,6.alpha.)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt)
  • Morphinan-6.alpha.-ol, 4,5.alpha.-epoxy-3-methoxy-17-methyl-, tartrate (1:1)
  • Hydrocodeine hydrogen tartrate
  • Hydrocodeine bitartrate
  • Codeine, dihydro-, tartrate (1:1)
  • 4,5alpha-epoxy-6alpha-hydroxy-3-methoxy-17-methylmorphinan hydrogen [R-(R*,R*)]-tartrate
  • DIHYDROCODEINE BITARTRATE CII (200 MG)I0D2050.997MG/MG(DR)
  • dihydro-codeintartrate(1:1)
  • dihydrocodeinebitartrate
  • dihydrocodeineacidtartrate
  • df118
  • 4,5alpha-epoxy-3-methoxy-17-methyl-morphinan-6alpha-otartrate(1:1)(sal
  • 4,5-alpha-epoxy-3-methoxy-17-methyl-morphinan-6-alpha-otartrate(1:1)
  • Dihydrocodeine Bitartrate CII (200 mg)